Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8109)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang X, Xu ZJ, Chen X, Zeng SS, Qian L, Wei J, Peng M, Wang X, Liu WL, Ma HY, Gong ZC, Yan YL. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients. World J Gastroenterol 2019; 25(17): 2099-2109 [PMID: 31114136 DOI: 10.3748/wjg.v25.i17.2099] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v25/i17/2099.htm |
| Number | Citing Articles |
| 1 |
OlusegunIsaac Alatise, Olalekan Olasehinde, AbdulfataiBamidele Olokoba, BabatundeM Duduyemi, OlusolaC Famurewa, OludareF Adeyemi, ElugwaraonuA Agbakwuru, AW Asombang. Colorectal cancer screening guidelines for Nigeria in 2019. NIGERIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2019; 11(2): 42 doi: 10.4103/NJGH.NJGH_15_20
|
| 2 |
Yi Zhang, Yunfei Xu, Yuzhi Wang. Alternative polyadenylation associated with prognosis and therapy in colorectal cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11089-9
|
| 3 |
Sorina Andreea Anghel, Corina-Bianca Ioniță-Mîndrican, Ioana Luca, Anca Lucia Pop. Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review. Cancers 2021; 13(19): 4965 doi: 10.3390/cancers13194965
|
| 4 |
Yu Jiang, Lei Liu, Qin Xiang, Xiaoqian He, Yan Wang, Dishu Zhou, Can Zou, Qian Chen, Mingyu Peng, Jin He, Xianyao Jiang, Tingxiu Xiang, Yucheng Yang. SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells. Clinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00833-5
|
| 5 |
Bi Peng, Jinwu Peng, Fanhua Kang, Wenqin Zhang, Emin Peng, Qingchun He. Ferroptosis-Related Gene MT1G as a Novel Biomarker Correlated With Prognosis and Immune Infiltration in Colorectal Cancer. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.881447
|
| 6 |
Liang Min, Jinghua Chen, Meihong Yu, Deliang Liu. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis. Journal of Clinical Medicine 2023; 12(2): 408 doi: 10.3390/jcm12020408
|
| 7 |
Huiqin Jiang, Qian Yu, Xinning Chen, Chunyan Zhang, Junfei Shen, Minna Shen, Yihui Yang, Beili Wang, Baishen Pan, Wei Guo. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients. Journal of Clinical Laboratory Analysis 2021; 35(11) doi: 10.1002/jcla.24030
|
| 8 |
Lei Liu, Qiao He, Yan Li, Bing Zhang, Xiaobin Sun, Jing Shan, Biran Pan, Tongtong Zhang, Zihao Zhao, Xiaoyu Song, Yuanbiao Guo. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer. Clinica Chimica Acta 2020; 509: 36 doi: 10.1016/j.cca.2020.05.048
|
| 9 |
Jie Sun, Min-Ying Zheng, Yu-Wei Li, Shi-Wu Zhang. Structure and function of Septin 9 and its role in human malignant tumors. World Journal of Gastrointestinal Oncology 2020; 12(6): 619-631 doi: 10.4251/wjgo.v12.i6.619
|
| 10 |
Samareh Younesian, Mohammad Hossein Mohammadi, Ommolbanin Younesian, Majid Momeny, Seyed H. Ghaffari, Davood Bashash. DNA methylation in human diseases. Heliyon 2024; 10(11): e32366 doi: 10.1016/j.heliyon.2024.e32366
|
| 11 |
Farah J. Nassar, Zahraa S. Msheik, Rihab R. Nasr, Sally N. Temraz. Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01095-5
|
| 12 |
Jiaxin Liu, Yimin Li, Yaqi Gan, Qing Xiao, Ruotong Tian, Guang Shu, Gang Yin. Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.671211
|
| 13 |
Zhijie Wang, Zixuan He, Rong Lin, Zhijie Feng, Xiuling Li, Xiangyu Sui, Lun Gu, Tian Xia, Dihan Zhou, Bali Zhao, Yanqing Li, Zhaoshen Li, Yu Bai. Evaluation of a plasma cell-free DNA methylation test for colorectal cancer diagnosis: a multicenter clinical study. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03662-y
|
| 14 |
Jie Wei, Zhijie Xu, Xi Chen, Xiang Wang, Shuangshuang Zeng, Long Qian, Xue Yang, Chunlin Ou, Wei Lin, Zhicheng Gong, Yuanliang Yan. Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10837
|
| 15 |
Yoshiaki Shoji, Satoru Furuhashi, Daniel F. Kelly, Anton J. Bilchik, Dave S. B. Hoon, Matias A. Bustos. Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy. Clinical & Experimental Metastasis 2022; 39(1): 61 doi: 10.1007/s10585-021-10094-y
|
| 16 |
Mengsi Yu, Changcheng Yang, Song Wang, Ying Shi, Jialu Wang, Cunren Meng, Li Xue, Zhaoyun Chen. Plasma Methylated SEPT9 as a Novel Biomarker for Predicting Liver Metastasis in Colorectal Cancer. Molecular Biotechnology 2024; 66(9): 2254 doi: 10.1007/s12033-023-00855-3
|
| 17 |
Zhi Yao Ma, Cherry Sze Yan Chan, Kam Shing Lau, Lui Ng, Yuen Yee Cheng, Wai K. Leung. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02879-8
|
| 18 |
Chenxi Wu, Jiayin Zhang, Haibo Li, Wenrong Xu, Xu Zhang. The potential of liquid biopsies in gastrointestinal cancer. Clinical Biochemistry 2020; 84: 1 doi: 10.1016/j.clinbiochem.2020.06.007
|
| 19 |
Susan Lou, Aasma Shaukat. Noninvasive strategies for colorectal cancer screening: opportunities and limitations. Current Opinion in Gastroenterology 2021; 37(1): 44 doi: 10.1097/MOG.0000000000000688
|
| 20 |
Haoran Tang, Xudong Ma, Lin Zhou, Wei Li, Yixiong Shu, Haichao Xu, Jiang Li, Feng Wang, Feng Sun, Yongqing Duan. Distinct Performance of Methylated SEPT9 in Upper and Lower Gastrointestinal Cancers and Combined Detection with Protein Markers. Genetic Testing and Molecular Biomarkers 2022; 26(4): 239 doi: 10.1089/gtmb.2021.0127
|
| 21 |
Shao-Ling Zhang, Hai-Jing Yu, Zhen-Qiang Lian, Jian Wan, Si-Mei Xie, Wen Lei, Qiu-Ping Chen, Liang Zhang, Qi Wang. Septin9 DNA methylation is associated with breast cancer recurrence or metastasis. Journal of International Medical Research 2024; 52(1) doi: 10.1177/03000605231220827
|
| 22 |
Can Fang, Rulei Zhong, Chenyang Qiu, Bing-bing Zou. The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.833013
|
| 23 |
Mingliang Huang, Jiehua He, Wei Lai, Lu Liu, Heyang Xu, Yujie Zeng, Qiusheng Lan, Xiangan Lin, Zhonghua Chu. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02172-6
|
| 24 |
Hao-Yun Luo, Hai-Ying Shen, R. Serene Perkins, Ya-Xu Wang. Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.908882
|